nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—ADRB1—dilated cardiomyopathy	0.479	0.543	CbGaD
Droxidopa—ADRB2—dilated cardiomyopathy	0.403	0.457	CbGaD
Droxidopa—Isoetarine—ADRB1—dilated cardiomyopathy	0.00128	0.161	CrCbGaD
Droxidopa—Isoetarine—ADRB2—dilated cardiomyopathy	0.00108	0.135	CrCbGaD
Droxidopa—Norepinephrine—SLC22A5—dilated cardiomyopathy	0.000713	0.0895	CrCbGaD
Droxidopa—Dopamine—SLC22A5—dilated cardiomyopathy	0.000663	0.0832	CrCbGaD
Droxidopa—Epinephrine—SLC22A5—dilated cardiomyopathy	0.000647	0.0812	CrCbGaD
Droxidopa—Isoprenaline—ADRB1—dilated cardiomyopathy	0.000532	0.0667	CrCbGaD
Droxidopa—Norepinephrine—ADRB1—dilated cardiomyopathy	0.000492	0.0618	CrCbGaD
Droxidopa—Dopamine—ADRB1—dilated cardiomyopathy	0.000458	0.0574	CrCbGaD
Droxidopa—Isoprenaline—ADRB2—dilated cardiomyopathy	0.000447	0.0561	CrCbGaD
Droxidopa—Epinephrine—ADRB1—dilated cardiomyopathy	0.000447	0.0561	CrCbGaD
Droxidopa—Epinephrine—TNF—dilated cardiomyopathy	0.000424	0.0532	CrCbGaD
Droxidopa—Norepinephrine—ADRB2—dilated cardiomyopathy	0.000414	0.052	CrCbGaD
Droxidopa—Epinephrine—ADRB2—dilated cardiomyopathy	0.000376	0.0472	CrCbGaD
Droxidopa—ADRA2B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	4.67e-05	0.000423	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.65e-05	0.000421	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.65e-05	0.000421	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—RAC1—dilated cardiomyopathy	4.65e-05	0.000421	CbGpPWpGaD
Droxidopa—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	4.65e-05	0.00042	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—AGT—dilated cardiomyopathy	4.64e-05	0.00042	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	4.61e-05	0.000417	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—CD36—dilated cardiomyopathy	4.61e-05	0.000417	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—AGT—dilated cardiomyopathy	4.57e-05	0.000413	CbGpPWpGaD
Droxidopa—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	4.54e-05	0.000411	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.54e-05	0.000411	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	4.51e-05	0.000408	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	4.44e-05	0.000401	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.42e-05	0.0004	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.42e-05	0.0004	CbGpPWpGaD
Droxidopa—DDC—Metabolism—GPX1—dilated cardiomyopathy	4.42e-05	0.0004	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.4e-05	0.000398	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.4e-05	0.000398	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.4e-05	0.000398	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	4.39e-05	0.000397	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.38e-05	0.000396	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	4.37e-05	0.000395	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—RAC1—dilated cardiomyopathy	4.35e-05	0.000393	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—AGT—dilated cardiomyopathy	4.34e-05	0.000392	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.33e-05	0.000392	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.33e-05	0.000392	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.33e-05	0.000391	CbGpPWpGaD
Droxidopa—DDC—Metabolism—CD36—dilated cardiomyopathy	4.3e-05	0.000389	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	4.3e-05	0.000389	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.26e-05	0.000386	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	4.24e-05	0.000384	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	4.24e-05	0.000383	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	4.24e-05	0.000383	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.19e-05	0.000379	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	4.19e-05	0.000379	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.09e-05	0.00037	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—AGT—dilated cardiomyopathy	4.06e-05	0.000367	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.03e-05	0.000364	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.03e-05	0.000364	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.02e-05	0.000363	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.99e-05	0.000361	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.97e-05	0.000359	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.94e-05	0.000356	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.94e-05	0.000356	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.94e-05	0.000356	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.94e-05	0.000356	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.9e-05	0.000353	CbGpPWpGaD
Droxidopa—DDC—Metabolism—AGT—dilated cardiomyopathy	3.88e-05	0.00035	CbGpPWpGaD
Droxidopa—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	3.86e-05	0.000349	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.85e-05	0.000348	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.85e-05	0.000348	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.82e-05	0.000346	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	3.82e-05	0.000345	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.81e-05	0.000344	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.79e-05	0.000342	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	3.77e-05	0.000341	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	3.75e-05	0.000339	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.73e-05	0.000337	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.67e-05	0.000332	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.66e-05	0.000331	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.66e-05	0.000331	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.64e-05	0.000329	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.63e-05	0.000328	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.58e-05	0.000324	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.58e-05	0.000324	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.58e-05	0.000323	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.58e-05	0.000323	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	3.55e-05	0.000321	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.54e-05	0.00032	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	3.53e-05	0.000319	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.48e-05	0.000315	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.47e-05	0.000314	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.47e-05	0.000314	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.47e-05	0.000313	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.45e-05	0.000312	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.44e-05	0.000311	CbGpPWpGaD
Droxidopa—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	3.43e-05	0.00031	CbGpPWpGaD
Droxidopa—PAH—Disease—EGFR—dilated cardiomyopathy	3.4e-05	0.000308	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.39e-05	0.000306	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.33e-05	0.000301	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.33e-05	0.000301	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.26e-05	0.000295	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.26e-05	0.000294	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.22e-05	0.000291	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.21e-05	0.00029	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.18e-05	0.000288	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.17e-05	0.000286	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.16e-05	0.000286	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.14e-05	0.000284	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.11e-05	0.000281	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.1e-05	0.00028	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.09e-05	0.00028	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—RAF1—dilated cardiomyopathy	3.08e-05	0.000279	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.08e-05	0.000279	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.08e-05	0.000279	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.03e-05	0.000274	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.01e-05	0.000272	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.97e-05	0.000268	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.97e-05	0.000268	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.96e-05	0.000268	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.96e-05	0.000267	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.94e-05	0.000266	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.93e-05	0.000265	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.9e-05	0.000262	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.88e-05	0.000261	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—RAF1—dilated cardiomyopathy	2.88e-05	0.000261	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.87e-05	0.00026	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.87e-05	0.000259	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.84e-05	0.000256	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—AGT—dilated cardiomyopathy	2.83e-05	0.000255	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.81e-05	0.000254	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.81e-05	0.000254	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.81e-05	0.000254	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.81e-05	0.000254	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.78e-05	0.000252	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.78e-05	0.000252	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.78e-05	0.000251	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.77e-05	0.000251	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.75e-05	0.000249	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.75e-05	0.000249	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.75e-05	0.000249	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.75e-05	0.000248	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.7e-05	0.000244	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.69e-05	0.000244	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—RAC1—dilated cardiomyopathy	2.68e-05	0.000243	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.67e-05	0.000241	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.64e-05	0.000238	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.62e-05	0.000237	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.61e-05	0.000236	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.61e-05	0.000236	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.6e-05	0.000235	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.6e-05	0.000235	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.59e-05	0.000234	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.58e-05	0.000234	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	2.57e-05	0.000233	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—AGT—dilated cardiomyopathy	2.56e-05	0.000232	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.56e-05	0.000232	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.56e-05	0.000232	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.56e-05	0.000232	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.56e-05	0.000231	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	2.55e-05	0.000231	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	2.52e-05	0.000228	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.51e-05	0.000227	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.49e-05	0.000226	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.48e-05	0.000224	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.45e-05	0.000222	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.42e-05	0.000219	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.4e-05	0.000217	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	2.38e-05	0.000215	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.38e-05	0.000215	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.38e-05	0.000215	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.37e-05	0.000214	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	2.35e-05	0.000212	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.34e-05	0.000212	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	2.34e-05	0.000212	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.31e-05	0.000208	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.29e-05	0.000207	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.27e-05	0.000206	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.27e-05	0.000206	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.25e-05	0.000203	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.23e-05	0.000202	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.18e-05	0.000197	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.16e-05	0.000195	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.14e-05	0.000194	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.13e-05	0.000193	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.11e-05	0.000191	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.11e-05	0.000191	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.11e-05	0.000191	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.11e-05	0.000191	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	2.08e-05	0.000188	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.06e-05	0.000187	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.05e-05	0.000185	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.05e-05	0.000185	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.03e-05	0.000184	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.03e-05	0.000183	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	2e-05	0.000181	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.97e-05	0.000178	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.96e-05	0.000178	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.96e-05	0.000177	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.94e-05	0.000175	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.93e-05	0.000175	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	1.92e-05	0.000174	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.9e-05	0.000172	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.9e-05	0.000172	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	1.87e-05	0.000169	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.87e-05	0.000169	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.79e-05	0.000162	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—RAF1—dilated cardiomyopathy	1.78e-05	0.000161	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.77e-05	0.00016	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.76e-05	0.000159	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.75e-05	0.000158	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.75e-05	0.000158	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	1.75e-05	0.000158	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.75e-05	0.000158	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.72e-05	0.000156	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	1.68e-05	0.000152	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	1.67e-05	0.000151	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.66e-05	0.00015	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.65e-05	0.00015	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.63e-05	0.000147	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.63e-05	0.000147	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.62e-05	0.000147	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.6e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.59e-05	0.000144	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.58e-05	0.000143	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	1.56e-05	0.000141	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.56e-05	0.000141	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.54e-05	0.000139	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	1.52e-05	0.000138	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	1.52e-05	0.000137	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	1.51e-05	0.000136	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	1.49e-05	0.000135	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	1.47e-05	0.000133	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.45e-05	0.000131	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.45e-05	0.000131	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.43e-05	0.000129	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	1.41e-05	0.000127	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	1.39e-05	0.000125	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	1.37e-05	0.000124	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.34e-05	0.000122	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.34e-05	0.000121	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.32e-05	0.00012	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.29e-05	0.000116	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	1.23e-05	0.000111	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.23e-05	0.000111	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.22e-05	0.00011	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.21e-05	0.00011	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.2e-05	0.000108	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.2e-05	0.000108	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	1.16e-05	0.000105	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	1.14e-05	0.000103	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.13e-05	0.000103	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.12e-05	0.000101	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.06e-05	9.54e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.05e-05	9.46e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.03e-05	9.34e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.91e-06	8.96e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	9.77e-06	8.83e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	9.61e-06	8.69e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.21e-06	8.33e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	8.54e-06	7.72e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	7.94e-06	7.18e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	7.94e-06	7.17e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	7.24e-06	6.54e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	7.17e-06	6.48e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	7.08e-06	6.4e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	6.7e-06	6.06e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	6.59e-06	5.96e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	5.86e-06	5.3e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	5.44e-06	4.92e-05	CbGpPWpGaD
